Nimble Science Ltd.
13
3
5
2
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 60/100
7.7%
1 terminated/withdrawn out of 13 trials
66.7%
-19.8% vs industry average
8%
1 trials in Phase 3/4
0%
0 of 2 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (13)
Assessing Changes in the Gut Microbiome of Non-Gastrointestinal Disordered Subjects Before and After Oral Prebiotic Supplementation Using the SIMBA Capsule
Role: lead
Assessing Gut Microbiome Changes Before and After an Oral Nutritional Supplement Intake Using the SIMBA Capsule in Diabetic Participants
Role: lead
Effects of Milk-based Drinks on Gut Microbiome, Sleep and Cardiometabolic Markers
Role: collaborator
The Digestion of Protein Powders in Healthy Participants Using SIMBA and LIMBA Capsule
Role: lead
Evaluation of the Microbiome in Multiple Sclerosis
Role: lead
The Safety And Efficacy Of A Probiotic Intervention On Lactulose Hydrogen Breath Test-Positive Patients And Related Gastrointestinal Symptoms
Role: lead
Evaluation of the SIMBA Capsule for Small Intestinal Dysbiosis
Role: lead
To Evaluate the Feasibility of Collecting Duodenal Fluid With SIMBA Capsules
Role: collaborator
Observational Small Intestine and Blood Fingerprint (SmIle) Study in Parkinson's Disease
Role: lead
Assessing the Safety of an IGY Supplement on the Gut Microbiome
Role: lead
A Clinical Trial of Fecal Microbiota Transplantation in a Population With Obsessive-compulsive Disorder
Role: collaborator
Validation of the Small Intestine Microbiome Aspiration (SIMBA) Capsule
Role: collaborator
Dietary Intervention Detection in the Small Intestine
Role: lead
All 13 trials loaded